Over 100 Washington Auctions End Today - Bid Now

Sirona Medical partners with RevealDX to transform lung cancer screening with a comprehensive suite of reimbursed AI tools

Press releases may be edited for formatting or style | November 17, 2022 Artificial Intelligence
SAN FRANCISCO, Nov. 17, 2022 /PRNewswire/ -- Sirona Medical, the leader in cloud-native radiology workflow software, today announced a comprehensive distribution and collaboration partnership with RevealDX and the integration of Nines' FDA-cleared automated measurement tool recently acquired by Sirona to improve end to end care for patients with lung nodules.

"There are several limitations to lung cancer screening programs. The most notable are inefficient methods for nodule detection and measurement as well as suboptimal specificity for lung cancer detection," notes Dr. Mohit Naik, M.D., President of Hackensack Radiology Group (HRG). "Sirona Medical is in a unique position to solve both of these challenges. Sirona's automated lung nodule measurement tool will dramatically streamline radiologists' workflow. Furthermore their partnership with Reveal-DX will help identify nodules at highest risk for malignancy. HRG is excited to deepen our partnership with Sirona and incorporate this comprehensive solution into our workflow."

HRG and Triad Radiology Associates (TRA), two of the nation's leading private radiology practices, have partnered with Sirona to use the comprehensive solution after production testing early next year, and to develop additional tools to deliver better lung cancer care to their patients going forward.

Sirona's core Workspace platform provides radiologists with a cloud-native workflow solution, delivering the viewing, reporting, universal worklist, and PACS archive that radiologists need in a unified zero-footprint format. Embedded into Sirona Workspace, the Sirona+RevealDX lung workflow can be deployed as an overlay to practices' existing PACS & RIS systems. This provides meaningful value to radiologists quickly and easily:

Significant Return on Investment: Starting in 2023, providers in the United States can submit for reimbursement to CMS (HOPPS) using code 0721T/0722T (APC 1508 Level 8) which is paid between $600 and $700 (contingent on pending FDA clearance for RevealDX in 2023).
Swift, simple integration: Sirona's novel cloud-native architecture enables customers to go live within a week of contracting (20-40 hrs of one IT resource's time). A DICOM & HL7 feed is all that's required to integrate, no servers necessary.
Software cost savings: Preferred pricing on PACS Archiving and other Sirona solutions.
Efficiency & quality in a single click: Faster, higher-quality diagnoses powered by a new approach to clinical AI.

You Must Be Logged In To Post A Comment